1. Introduction
1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:
4. Europe Genome Editing Market Landscape
4.1 Market Overview
4.2 Porter's Five Forces Analysis
- 4.2.1 Bargaining Power of Suppliers
- 4.2.2 Bargaining Power of Buyers
- 4.2.3 Threat of New Entrants
- 4.2.4 Competitive Rivalry
- 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
- 4.3.1 Raw Material Suppliers
- 4.3.2 Manufacturers
- 4.3.3 Distributors/Suppliers
- 4.3.4 End Users
5. Europe Genome Editing Market – Key Market Dynamics
5.1 Growth Drivers
- 5.1.1 Advancements in CRISPR and gene-editing technologies
- 5.1.2 Increasing investments in genomic research and personalized medicine
5.2 Market Opportunities
- 5.2.1 Advancements in genetic research and personalized medicine creating growth opportunities in genome editing technologies
- 5.2.2 Expanding research funding opening new avenues for innovation
5.3 Future Trends
- 5.3.1 Application of genome editing for genetic disease treatment
- 5.3.2 Expanding research in CRISPR technology for genetic therapies
5.4 Impact of Drivers and Restraints
6. Europe Genome Editing Market Regional Analysis
6.1 Europe Genome Editing Market Overview
6.2 Europe Genome Editing Market Revenue 2019-2028 (US$ Million)
6.3 Europe Genome Editing Market Forecast Analysis
7. Europe Genome Editing Market Analysis – by Technology
7.1 CRISPR
- 7.1.1 Overview
- 7.1.2 CRISPR: Europe Genome Editing Market – Revenue and Forecast to 2031 (US$ Million)
7.2 TALEN
- 7.2.1 Overview
- 7.2.2 TALEN: Europe Genome Editing Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Antisense
- 7.3.1 Overview
- 7.3.2 Antisense: Europe Genome Editing Market – Revenue and Forecast to 2031 (US$ Million)
8. Europe Genome Editing Market Analysis – by Application
8.1 Cell Line Engineering
- 8.1.1 Overview
- 8.1.2 Cell Line Engineering: Europe Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)
8.2 Genetic Engineering
- 8.2.1 Overview
- 8.2.2 Genetic Engineering: Europe Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)
8.3 Diagnostic Applications
- 8.3.1 Overview
- 8.3.2 Diagnostic Applications: Europe Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Drug Discovery
- 8.4.1 Overview
- 8.4.2 Drug Discovery: Europe Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)
9. Europe Genome Editing Market Analysis – by End User
9.1 Pharmaceutical and Biotechnology Companies
- 9.1.1 Overview
- 9.1.2 Drug Discovery: Europe Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)
9.2 Academic and Research Institutes
- 9.2.1 Overview
- 9.2.2 Drug Discovery: Europe Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)
9.3 Clinical Research Organizations
- 9.3.1 Overview
- 9.3.2 Drug Discovery: Europe Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)
10. Europe Genome Editing Market – Europe Analysis
10.1 Europe
- 10.1.1 Europe Genome Editing Market Breakdown, by Key
Country, 2022 and 2028 (%)
- 10.1.1.1 Europe Genome Editing Market – Revenue and
Forecast Analysis – by Country
- 10.1.1.1 UK:
Europe Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.1.1 UK: Europe Genome Editing Market Breakdown, by Technology
- 10.1.1.1.2 UK: Europe Genome Editing Market Breakdown, by Application
- 10.1.1.1.3 UK: Europe Genome Editing Market Breakdown, by End User
- 10.1.1.2 Germany:
Europe Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.2.1 Germany: Europe Genome Editing Market Breakdown, by Technology
- 10.1.1.2.2 Germany: Europe Genome Editing Market Breakdown, by Application
- 10.1.1.2.3 Germany: Europe Genome Editing Market Breakdown, by End User
- 10.1.1.3 France:
Europe Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.3.1 France: Europe Genome Editing Market Breakdown, by Technology
- 10.1.1.3.2 France: Europe Genome Editing Market Breakdown, by Application
- 10.1.1.3.3 France: Europe Genome Editing Market Breakdown, by End User
- 10.1.1.4 Russia:
Europe Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.4.1 Russia: Europe Genome Editing Market Breakdown, by Technology
- 10.1.1.4.2 Russia: Europe Genome Editing Market Breakdown, by Application
- 10.1.1.4.3 Russia: Europe Genome Editing Market Breakdown, by End User
- 10.1.1.5 Italy:
Europe Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.5.1 Italy: Europe Genome Editing Market Breakdown, by Technology
- 10.1.1.5.2 Italy: Europe Genome Editing Market Breakdown, by Application
- 10.1.1.5.3 Italy: Europe Genome Editing Market Breakdown, by End User
- 10.1.1.6 Rest of Europe:
Europe Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.6.1 Rest of Europe: Europe Genome Editing Market Breakdown, by Technology
- 10.1.1.6.2 Rest of Europe: Europe Genome Editing Market Breakdown, by Application
- 10.1.1.6.3 Rest of Europe: Europe Genome Editing Market Breakdown, by End User
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Europe Genome Editing Market Industry Landscape
12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments
13. Company Profiles
13.1 THERMO FISHER SCIENTIFIC INC.
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 MERCK KGaA
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Lonza
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Horizon Discovery Group plc.
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Integrated DNA Technologies
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 GenScript
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 New England Biolabs
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Eurofins Scientific
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 CRISPR Therapeutics
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
14. Appendix
14.1 About Business Market Insights